STERIS plc (NYSE:STE) Receives Consensus Recommendation of “Moderate Buy” from Analysts

STERIS plc (NYSE:STE) has been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $273.50.

Separately, Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th.

Insider Activity

In other STERIS news, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the transaction, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. This trade represents a 31.86% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP John Adam Zangerle sold 15,000 shares of STERIS stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the transaction, the vice president owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 25,044 shares of company stock worth $6,586,218 over the last 90 days. 1.07% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Steigerwald Gordon & Koch Inc. purchased a new stake in STERIS in the 3rd quarter valued at approximately $25,000. Board of the Pension Protection Fund acquired a new position in shares of STERIS in the fourth quarter worth $25,000. Harbor Investment Advisory LLC raised its holdings in shares of STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 60 shares during the last quarter. Spurstone Advisory Services LLC purchased a new stake in shares of STERIS in the second quarter valued at $29,000. Finally, Cloud Capital Management LLC acquired a new stake in shares of STERIS during the third quarter valued at $29,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

STERIS Stock Up 0.1%

STE stock opened at $263.34 on Wednesday. The company has a market cap of $25.85 billion, a P/E ratio of 37.84 and a beta of 1.03. STERIS has a 52 week low of $204.90 and a 52 week high of $269.44. The company’s 50-day moving average price is $259.10 and its 200 day moving average price is $248.17. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same period last year, the company posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, research analysts expect that STERIS will post 9.08 earnings per share for the current fiscal year.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.